Published in J Clin Oncol on July 16, 2012
From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull (2014) 2.39
The Emerging Field of Human Social Genomics. Clin Psychol Sci (2013) 1.57
Surviving and thriving with cancer using a Web-based health behavior change intervention: randomized controlled trial. J Med Internet Res (2014) 1.03
Biobehavioral approaches to cancer progression and survival: Mechanisms and interventions. Am Psychol (2015) 0.94
Behavioral research in cancer prevention and control: a look to the future. Am J Prev Med (2014) 0.83
Social support, self-efficacy for decision-making, and follow-up care use in long-term cancer survivors. Psychooncology (2014) 0.83
Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tract. BMC Cancer (2012) 0.82
Psychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovations. Brain Behav Immun (2013) 0.82
Breast cancer and social environment: getting by with a little help from our friends. Breast Cancer Res (2016) 0.82
Does caregiving cause psychological distress? The case for familial and genetic vulnerabilities in female twins. Ann Behav Med (2014) 0.82
Higher vagal activity as related to survival in patients with advanced breast cancer: an analysis of autonomic dysregulation. Psychosom Med (2015) 0.81
Patients' and oncologists' views on the treatment and care of advanced ovarian cancer in the U.K.: results from the ADVOCATE study. Br J Cancer (2013) 0.80
Importance of adrenergic pathways in women's cancers. Cancer Biomark (2013) 0.80
Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients. Gynecol Oncol (2013) 0.79
Fighting cancer together: Development and implementation of shared medical appointments to standardize and improve chemotherapy education. Gynecol Oncol (2015) 0.79
Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis. Oncogene (2015) 0.78
Why stress is BAD for cancer patients. J Clin Invest (2013) 0.78
Using the stress and adversity inventory as a teaching tool leads to significant learning gains in two courses on stress and health. Stress Health (2013) 0.78
PTSD symptoms as a consequence of breast cancer diagnosis: clinical implications. Springerplus (2014) 0.77
The influence of social support on hematopoietic stem cell transplantation survival: a systematic review of literature. PLoS One (2013) 0.76
Psychosocial factors and mortality in women with early stage endometrial cancer. Br J Health Psychol (2013) 0.76
Targeting those with decreased meaning and peace: a supportive care opportunity. Support Care Cancer (2014) 0.76
Diurnal cortisol rhythms, fatigue and psychosocial factors in five-year survivors of ovarian cancer. Psychoneuroendocrinology (2017) 0.75
Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301). Psychooncology (2015) 0.75
PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: study protocol for a randomized controlled trial. Trials (2017) 0.75
Relationships between social isolation, neighborhood poverty, and cancer mortality in a population-based study of US adults. PLoS One (2017) 0.75
Screening of Psychological Distress in Cancer Patients During Chemotherapy: A Cross-sectional Study. Indian J Palliat Care (2015) 0.75
Stress and cancer: Nordic pieces to the complex puzzle. Eur J Epidemiol (2015) 0.75
Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2016) 0.75
Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach. Gynecol Oncol (2017) 0.75
Cancer patients' preferences for therapy decisions can be grouped into categories and separated by demographic factors. J Cancer Res Clin Oncol (2017) 0.75
Social relationships and health. Science (1988) 21.36
Stress, social support, and the buffering hypothesis. Psychol Bull (1985) 19.28
Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight. Psychol Rev (2000) 8.13
The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry (1992) 7.36
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med (2006) 6.18
Social regulation of gene expression in human leukocytes. Genome Biol (2007) 4.65
Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med (2006) 4.41
Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res (2006) 3.58
The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res (2010) 3.36
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med (2000) 3.26
Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol (2006) 3.09
A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol Psychiatry (2008) 3.08
Social support and adjustment to cancer: reconciling descriptive, correlational, and intervention research. Health Psychol (1996) 2.46
Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res (2004) 2.35
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res (2006) 2.32
Decreased cancer survival in individuals separated at time of diagnosis: critical period for cancer pathophysiology? Cancer (2009) 2.24
Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J Clin Invest (2010) 2.04
Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis. Cancer Biol Ther (2006) 1.92
Associations of social networks with cancer mortality: a meta-analysis. Crit Rev Oncol Hematol (2009) 1.90
Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer (2005) 1.79
Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun (2008) 1.71
Depression, social support, and beta-adrenergic transcription control in human ovarian cancer. Brain Behav Immun (2008) 1.66
Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. J Biol Chem (2007) 1.65
Social support, psychological distress, and natural killer cell activity in ovarian cancer. J Clin Oncol (2005) 1.61
Social support and stress in the transition to parenthood. J Abnorm Psychol (1984) 1.58
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res (2007) 1.53
Social and emotional loneliness: an examination of Weiss's typology of loneliness. J Pers Soc Psychol (1984) 1.52
Host factors and cancer progression: biobehavioral signaling pathways and interventions. J Clin Oncol (2010) 1.47
Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma. Clin Cancer Res (2008) 1.46
The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. Cancer Res (2000) 1.45
The prognostic significance of psychosocial factors in women with breast cancer. J Chronic Dis (1987) 1.45
Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer (2002) 1.45
Social support and cancer progression: a systematic review. J Psychosom Res (2009) 1.43
Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Cancer Res (2003) 1.42
Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun (2010) 1.39
Effects of social relationships on survival for women with breast cancer: a prospective study. Soc Sci Med (1991) 1.36
Social relations, social support and survival among patients with cancer. J Psychosom Res (1992) 1.27
Baseline psychosocial predictors of survival in localised breast cancer. Br J Cancer (2006) 1.16
Diverse antiapoptotic signaling pathways activated by vasoactive intestinal polypeptide, epidermal growth factor, and phosphatidylinositol 3-kinase in prostate cancer cells converge on BAD. J Biol Chem (2006) 1.13
VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav Immun (2007) 1.08
Direct and buffering effects of social support among gynecologic cancer survivors. Ann Behav Med (2010) 1.07
Social environment and breast cancer. A cohort analysis of patient survival. Cancer (1983) 1.07
In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen, and prolactin. J Natl Cancer Inst (1984) 1.06
Social support and survival among women with breast cancer. Cancer (1995) 1.06
Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer. Genes Chromosomes Cancer (2008) 1.02
Dopamine blocks stress-mediated ovarian carcinoma growth. Clin Cancer Res (2011) 1.00
Does emotional support influence survival? Findings from a longitudinal study of patients with advanced cancer. Support Care Cancer (2004) 0.94
Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo. Int J Cancer (2004) 0.87
Social support and survival in patients with acute myeloid leukaemia. Support Care Cancer (2006) 0.87
Does marital status and altered contact with the social network predict colorectal cancer survival? Eur J Cancer (2006) 0.84
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med (2008) 8.77
Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA (2011) 6.81
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med (2006) 6.18
MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol (2011) 5.46
Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med (2002) 5.39
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup. J Clin Oncol (2009) 5.37
Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer (2011) 5.28
Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics (2005) 4.39
Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA (2010) 4.31
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer (2006) 4.27
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res (2005) 4.24
Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med (2015) 3.75
Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol (2008) 3.68
Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res (2006) 3.58
Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med (2012) 3.54
RNA interference in the clinic: challenges and future directions. Nat Rev Cancer (2010) 3.43
The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res (2010) 3.36
Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial. Arch Intern Med (2011) 3.11
Regulation of tumor angiogenesis by EZH2. Cancer Cell (2010) 3.10
Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension (2006) 3.02
A functional genomic perspective on human well-being. Proc Natl Acad Sci U S A (2013) 2.98
Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol (2008) 2.90
Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol (2011) 2.90
Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol (2011) 2.87
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res (2006) 2.86
Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res (2010) 2.80
Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers. Am J Clin Pathol (2005) 2.78
Central retinal artery occlusion: visual outcome. Am J Ophthalmol (2005) 2.69
Central retinal artery occlusion. Retinal survival time. Exp Eye Res (2004) 2.67
Resiliency in the face of disadvantage: do Hispanic cultural characteristics protect health outcomes? J Pers (2009) 2.53
Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med (2011) 2.53
Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res (2003) 2.50
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res (2005) 2.48
Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. Cancer (2003) 2.48
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. J Natl Cancer Inst (2008) 2.40
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. J Natl Cancer Inst (2008) 2.37
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell (2013) 2.34
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res (2006) 2.32
Computational identification of gene-social environment interaction at the human IL6 locus. Proc Natl Acad Sci U S A (2010) 2.31
Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer. Mol Cancer Ther (2010) 2.27
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. J Clin Oncol (2005) 2.24
Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol (2013) 2.24
Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res (2010) 2.19
Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med (2011) 2.18
Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology (2007) 2.17
Cardiometabolic risk in adolescents: associations with physical activity, fitness, and sleep. Ann Behav Med (2013) 2.07
Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J Clin Invest (2010) 2.04
Low yield of residual vulvar carcinoma and dysplasia upon re-excision for close or positive margins. Gynecol Oncol (2013) 2.01
Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res (2007) 1.98
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc Natl Acad Sci U S A (2011) 1.97
Platelets increase the proliferation of ovarian cancer cells. Blood (2012) 1.97
Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol (2004) 1.97
Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary. Obstet Gynecol (2006) 1.93
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. Cancer Res (2007) 1.90
A novel platform for detection of CK+ and CK- CTCs. Cancer Discov (2011) 1.88
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer. Clin Cancer Res (2008) 1.88
Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer. J Natl Cancer Inst (2006) 1.87
Mindfulness-Based Stress Reduction training reduces loneliness and pro-inflammatory gene expression in older adults: a small randomized controlled trial. Brain Behav Immun (2012) 1.86
Fundus changes in central retinal artery occlusion. Retina (2007) 1.85
Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res (2011) 1.84
Use of herbs among adults based on evidence-based indications: findings from the National Health Interview Survey. Mayo Clin Proc (2007) 1.84
Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via β-adrenergic induction of myelopoiesis. Proc Natl Acad Sci U S A (2013) 1.81
EphA2 expression is associated with aggressive features in ovarian carcinoma. Clin Cancer Res (2004) 1.80
Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer (2005) 1.79
Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology (2009) 1.78
Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer. J Natl Cancer Inst (2013) 1.78
HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma. Clin Cancer Res (2008) 1.77
Diurnal cortisol variations and symptoms in patients with interstitial cystitis. J Urol (2002) 1.73
Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res (2009) 1.73
Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models. Cancer Biol Ther (2010) 1.71
Symposium part 3: Should pathologists diagnose endocervical preneoplastic lesions "less than" adenocarcinoma in situ?: Point. Int J Gynecol Pathol (2003) 1.71
Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma. Cancer Res (2007) 1.68
Use of a new method in reaching consensus on the cause of cytologic-histologic correlation discrepancy. Am J Clin Pathol (2006) 1.68
Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer. Cancer Res (2007) 1.66
Depression, social support, and beta-adrenergic transcription control in human ovarian cancer. Brain Behav Immun (2008) 1.66
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. Lancet Oncol (2011) 1.65
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. Cancer Res (2008) 1.65
Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. Gastroenterology (2011) 1.64
Natural history of visual outcome in central retinal vein occlusion. Ophthalmology (2010) 1.64
Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells. Clin Cancer Res (2005) 1.63
Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol (2006) 1.63
Src activation by β-adrenoreceptors is a key switch for tumour metastasis. Nat Commun (2013) 1.62
Therapeutic Targeting of ATP7B in Ovarian Carcinoma. Clin Cancer Res (2009) 1.61
Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics (2005) 1.61
Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies. J Clin Oncol (2012) 1.61
Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant. Gynecol Oncol (2009) 1.61